Home › Tumori cerebrali › Texas › Houston
Studi clinici su Tumori cerebrali a Houston, TX
35 studi su Tumori cerebrali cercano partecipanti presso sedi a Houston e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
In reclutamentoFase 1
- Baylor St. Luke's Medical Center, Houston
Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR BeaM)
In reclutamentoFase 2
- The University of Texas M. D. Anderson Cancer Center, Houston
A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
In reclutamentoFase 2
- M D Anderson Cancer Center, Houston
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
In reclutamentoFase 1/2
- MD Anderson Cancer Center, Houston
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
In reclutamentoFase 2
- Local Institution - 0085, Houston
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
In reclutamentoFase 2
- Texas Children's Hospital, Houston
OBSERVE: A Pilot Study Of Omission Of Brain Metastasis Stereotactic Radiosurgery Following Resection With CNS-Active Systemic Therapy
In reclutamentoFase 1
- MD Anderson Cancer Center, Houston
Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
In reclutamentoStudio osservazionale
- M D Anderson Cancer Center, Houston
A Phase 1/1b Study of IAM1363 in HER2 Cancers
In reclutamentoFase 1
- MD Anderson Cancer Center - University of Texas, Houston
A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers
In reclutamentoStudio osservazionale
- MD Anderson Cancer Center, Houston
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
In reclutamentoFase 1/2
- University of Texas MD Anderson Cancer Center, Houston
Targeted Pediatric High-Grade Glioma Therapy
In reclutamentoStudio osservazionale
- Texas Children's Hospital, Houston
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
In reclutamentoFase 2
- UT MD Anderson Cancer Center, Houston
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
In reclutamentoFase 1
- MD Anderson Cancer Center, Houston
Study of Olutasidenib and Temozolomide in HGG
In reclutamentoFase 2
- Texas Children's Hospital, Houston
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
In reclutamentoFase 2
- MD Anderson Cancer Center, Houston
A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases
In reclutamentoFase 1
- The University of Texas M.D. Anderson Cancer Center, Houston
Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection
In reclutamentoFase 2
- Houston Methodist Neal Cancer Center, Houston
Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
In reclutamentoFase 1
- Excel Diagnostics & Nuclear Oncology Center, Houston
C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
In reclutamentoFase 1
- Texas Children's Hospital, Houston
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
In reclutamentoStudio osservazionale
- Baylor St. Luke's Medical Center | Baylor College of Medicine, Houston
- Houston Methodist Hospital, Houston
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
In reclutamentoFase 1
- M D Anderson Cancer Center, Houston
A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)
In reclutamentoFase 2
- M D Anderson Cancer Center, Houston
Mapping of Human Cognition
In reclutamento
- The University of Texas Health Science Center at Houston, Houston
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
In reclutamentoFase 2
- Texas Children's Hospital, Houston
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
In reclutamento
- M D Anderson Cancer Center, Houston
A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain
In reclutamentoStudio osservazionale
- M D Anderson Cancer Center, Houston
Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
In reclutamentoFase 2
- M D Anderson Cancer Center, Houston
EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-active
In reclutamentoFase 2
- The University of Texas MD Anderson Cancer Center, Houston
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
In reclutamentoFase 1/2
- MD Anderson Cancer Center, Houston
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
In reclutamentoStudio osservazionale
- Md Anderson Cancer Center, Houston
Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)
In reclutamentoFase 2
- M D Anderson Cancer Center, Houston
Virtual Home-based Exercise Intervention (RISE) to Improve Cancer-Related Cognitive Impairment and Gut Microbiome in Adolescent and Young Adult Brain Tumor Survivors
In reclutamento
- MD Anderson Cancer Center, Houston
Systematic Light Exposure in Pediatric Brain Tumor Survivors
In reclutamento
- Texas Children's Hospital, Houston
A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
In reclutamentoFase 1/2
- MD Anderson, Houston
Studi su Tumori cerebrali in altre città
- Boston, MA28 studi
- New York City, NY25 studi
- Washington, DC20 studi
- Los Angeles, CA16 studi
- Miami, FL15 studi
- Durham, NC14 studi
- St. Louis, MO12 studi
- Cleveland, OH11 studi
- Seattle, WA11 studi
- Rochester, MN11 studi
- Baltimore, MD11 studi
- Columbus, OH11 studi
Altri studi a Houston
- Cancro del polmone non a piccole cellule145 studi
- Cancro al seno126 studi
- Cancro (tutti i tipi)121 studi
- Cancro metastatico104 studi
- Cancro colorettale102 studi
- Cancro ovarico89 studi
- Leucemia mieloide acuta85 studi
- Cancro ai polmoni78 studi
- Cancro alla prostata76 studi
- Cancro dell'endometrio68 studi
- Cancro pancreatico61 studi
- Melanoma59 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.